FB VISION, Ascoli Piceno, Italy
CompanyItaly
FB VISION, Ascoli Piceno, Italy develops 2 assets, the furthest in human trials (Neuprozin mito in glaucoma). Mostly supplement acting on Oxidative stress and ROS signalling and Mitochondrial biogenesis (PGC-1α); based in Italy.
- 2
- Assets
- Furthest stage
- Human trials
- 0
- Trials
- 1
- Signal
Pipeline
2Fixed combination of citicoline, nicotinamide, PQQ, and homotaurine to reduce mitochondrial dysfunction and oxidative stress.
Human trials, Supplement, Oxidative stress and ROS signalling, Mitochondrial biogenesis (PGC-1α), glaucoma
Citicoline dietary supplement providing neuroprotection to retinal ganglion cells.
Human trials, Supplement, glaucoma
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials1
- Signals1
- Similar companies6